Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Pivotal CRO is a full-service clinical research organization headquartered in Madrid, Spain. Founded in 2001, it positions itself as a “next-generation CRO” for biotechnology companies. Based on the website information, it is not a typical subscription-based SaaS product, but rather a clinical trial operations service provider, supplemented by technologies such as a real-time analytics platform, AI-driven RBQM, site profiling, and trial insights.
Its services cover the full clinical development lifecycle, including study start-up and regulatory affairs, project management, patient recruitment and retention, clinical monitoring, medical services and medical monitoring, pharmacovigilance, data science, biostatistics, quality assurance and compliance, and decentralized clinical trials. Therapeutic areas include oncology and hematology, rare diseases, neuroscience, metabolism and endocrinology, cardiovascular disease, infectious diseases and vaccines, ATMPs, and more. The website states that it has participated in more than 540 trials and operates in over 25 countries.
The website does not disclose standard packages, subscription pricing, or module-based pricing. Instead, customized solutions are mainly obtained by submitting an RFP, booking a meeting, or sending an inquiry. The site offers a “Request a Danah Demo” option, but does not explain Danah’s specific product scope, trial policy, deployment model, APIs, or enterprise permission system.
Its strengths lie in its vertical focus on biotechnology companies, with an emphasis on flexibility, medical team involvement, and clinical quality. It also has offices across multiple European locations and extends its global trial execution capabilities through partners. Its DCT solution mentions the use of wearable devices, telemedicine platforms, eCOA/ePRO, remote monitoring, and real-time insights. The main drawback, from an enterprise software evaluation perspective, is the lack of key information such as third-party integration lists, data security certifications, cloud/self-hosted deployment options, API documentation, and permission models.
It is better suited for biotechnology companies that need clinical trial execution support in Europe and globally, especially for early-stage research, pivotal trials, oncology, rare diseases, ATMPs, and decentralized trial projects. It is not a good fit for teams that simply want to purchase a standardized SaaS clinical data platform, CTMS, or ePRO tool and require clear pricing and API documentation.
The crawled content does not provide information on access from mainland China, ICP filing, CDN support, or localized services, so its access status in China is assessed as unknown.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on pivotalcr.com official site.
pivotalcr.com is an Spain Health provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach pivotalcr.com directly.